REBECCA ALLEN: Open Payments
NPI 1841937315 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$758 in 37 payments from 12 companies in 2025. Trend: 2023 $324 · 2024 $449 · 2025 $758
Food & beverage: $758
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $177 |
| ABBVIE INC. | 8 | $136 |
| Olympus America Inc. | 1 | $72 |
| Lilly USA, LLC | 3 | $64 |
| Ardelyx, Inc. | 3 | $53 |
| QOL Medical, LLC | 3 | $52 |
| Madrigal Pharmaceuticals | 2 | $49 |
| GENZYME CORPORATION | 2 | $46 |
| Aimmune Therapeutics, Inc. | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
Products named: ENTYVIO, VISIGLIDE, DUPIXENT, OMVOH, LINZESS, EOHILIA, IBSRELA, Sucraid.
Industry payments across IN — which companies pay providers there.
